| Mrs Mary M Luder, ARNP | |
|
12200 W 106th Street Suite 130, Overland Park, KS 66215-2305 | |
| (913) 307-0044 | |
| (913) 227-0094 |
| Full Name | Mrs Mary M Luder |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 20 Years |
| Location | 12200 W 106th Street Suite 130, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043299969 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Kansas Hospital Authority | 9436054798 | 250 |
News Archive
Three-dimensional visualization based on computer tomography imaging provides more thorough preparation for the diagnosis of lung diseases.
Bariatric surgery, which significantly curtails the amount of food a person can eat, is the most effective treatment against obesity and is being recognized as a potentially valuable tool in the fight against diabetes related to obesity.
Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.
Americans spend $25 billion a year on dietary supplement products such as herbs and other botanicals. While the Nutrition Business Journal forecasts that sales of botanical dietary supplements will increase by about 19 percent over the next five years, scientists still don't know the precise properties that make certain plants helpful or harmful to humans. Now, with a new $7.5 million grant from the National Institutes of Health, University of Missouri researchers have created a National Botanical Research Center to answer these questions.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 6 days ago
| Entity Name | University Of Kansas Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528019502 PECOS PAC ID: 9436054798 Enrollment ID: O20050908001103 |
News Archive
Three-dimensional visualization based on computer tomography imaging provides more thorough preparation for the diagnosis of lung diseases.
Bariatric surgery, which significantly curtails the amount of food a person can eat, is the most effective treatment against obesity and is being recognized as a potentially valuable tool in the fight against diabetes related to obesity.
Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.
Americans spend $25 billion a year on dietary supplement products such as herbs and other botanicals. While the Nutrition Business Journal forecasts that sales of botanical dietary supplements will increase by about 19 percent over the next five years, scientists still don't know the precise properties that make certain plants helpful or harmful to humans. Now, with a new $7.5 million grant from the National Institutes of Health, University of Missouri researchers have created a National Botanical Research Center to answer these questions.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Mary M Luder, ARNP 12200 W 106th St, Suite 130, Overland Park, KS 66215-2305 Ph: (913) 307-0044 | Mrs Mary M Luder, ARNP 12200 W 106th Street Suite 130, Overland Park, KS 66215-2305 Ph: (913) 307-0044 |
News Archive
Three-dimensional visualization based on computer tomography imaging provides more thorough preparation for the diagnosis of lung diseases.
Bariatric surgery, which significantly curtails the amount of food a person can eat, is the most effective treatment against obesity and is being recognized as a potentially valuable tool in the fight against diabetes related to obesity.
Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.
Americans spend $25 billion a year on dietary supplement products such as herbs and other botanicals. While the Nutrition Business Journal forecasts that sales of botanical dietary supplements will increase by about 19 percent over the next five years, scientists still don't know the precise properties that make certain plants helpful or harmful to humans. Now, with a new $7.5 million grant from the National Institutes of Health, University of Missouri researchers have created a National Botanical Research Center to answer these questions.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 6 days ago
Tiffany M Kinnison, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 220a, Overland Park, KS 66211 Phone: 913-549-3884 Fax: 913-273-3343 | |
Gina Shay-zapien, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 12140 Nall Ave Ste 210, Overland Park, KS 66209 Phone: 913-906-9364 Fax: 913-906-9372 | |
Sandra L. Anderson, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 8901 W 74th St, Suite 269, Overland Park, KS 66204 Phone: 913-676-7585 Fax: 913-676-8189 | |
Terri Kaye Rose, RN, WHNP-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4401 W 109th St, Suite 200, Overland Park, KS 66211 Phone: 913-312-5100 | |
Valerie Alayne Edwards, ARNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 10500 Quivira Rd, Overland Park, KS 66215 Phone: 913-541-5000 | |
Mrs. Margaret R Sanford, ARNP WHNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6730 W 121st St, Overland Park, KS 66209 Phone: 913-307-0044 Fax: 913-948-5380 |